CUA Educational Content

Management of Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC): Putting Current Evidence into Practice

EDITORIAL COMMITTEE: Ricardo Rendon, Krista Noonan, Frank Papanikolaou, Bobby Shayegan, Troy Sitland, Alan So

By participating in this program, health care providers can expect to:

  • Describe the rationale for treating men with prostate cancer earlier in the non-metastatic CRPC state
  • Identify patients who are appropriate for treatment of their nmCRPC
  • Discuss treatment options in the management of nmCRPC
  • Describe appropriate follow-up of patients with nmCRPC
  • Devise strategies for implementing nmCRPC management practices

Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

 

This program has received financial support from Bayer in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy